Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth M Steinberg

Showing results (301-310 of 481) with videos related to

Pageof 49
Sort By:
Clinical Genitourinary Cancer|April 25, 2020
Phase 2 Study of Seviteronel (INO-464) in Patients With Metastatic Castration-Resistant Prostate Cancer After Enzalutamide TreatmentRavi A Madan, Keith T Schmidt, Fatima Karzai, et al.
Surgery|December 2, 2008
The utility of routine transcervical thymectomy for multiple endocrine neoplasia 1-related hyperparathyroidismAnathea C Powell, H Richard Alexander, James F Pingpank, et al.
British Journal of Haematology|September 28, 2021
Donor source and post-transplantation cyclophosphamide influence outcome in allogeneic stem cell transplantation for GATA2 deficiencyDiana X Nichols-Vinueza, Mark Parta, Nirali N Shah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 2018
Tumor-Derived GM-CSF Promotes Granulocyte Immunosuppression in Mesothelioma PatientsSwati Khanna, Suzanne Graef, Francis Mussai, et al.
Haematologica|May 12, 2018
End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R: a paradigm shift in clinical decision makingChristopher Melani, Ranjana Advani, Mark Roschewski, et al.
British Journal of Haematology|October 31, 2009
Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T-cell lymphomaSusan E Bates, Zhirong Zhan, Kenneth Steadman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2006
A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancerPhilip M Arlen, James L Gulley, Catherine Parker, et al.
Blood|September 25, 2015
ATM deficiency promotes development of murine B-cell lymphomas that resemble diffuse large B-cell lymphoma in humansKaren S Hathcock, Hesed M Padilla-Nash, Jordi Camps, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 11, 2009
Strategies to improve long-term outcome in stage IIIB inflammatory breast cancer: multimodality treatment including dose-intensive induction and high-dose chemotherapyClaude Sportès, Seth M Steinberg, David J Liewehr, et al.
Blood Advances|August 8, 2022
The impact of race, ethnicity, and obesity on CAR T-cell therapy outcomesAiman J Faruqi, John A Ligon, Paul Borgman, et al.
Pageof 49

Showing results (301-310 of 481) with videos related to

Sort By:
Pageof 49
Clinical Genitourinary Cancer|April 25, 2020
Phase 2 Study of Seviteronel (INO-464) in Patients With Metastatic Castration-Resistant Prostate Cancer After Enzalutamide TreatmentRavi A Madan, Keith T Schmidt, Fatima Karzai, et al.
Surgery|December 2, 2008
The utility of routine transcervical thymectomy for multiple endocrine neoplasia 1-related hyperparathyroidismAnathea C Powell, H Richard Alexander, James F Pingpank, et al.
British Journal of Haematology|September 28, 2021
Donor source and post-transplantation cyclophosphamide influence outcome in allogeneic stem cell transplantation for GATA2 deficiencyDiana X Nichols-Vinueza, Mark Parta, Nirali N Shah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 2018
Tumor-Derived GM-CSF Promotes Granulocyte Immunosuppression in Mesothelioma PatientsSwati Khanna, Suzanne Graef, Francis Mussai, et al.
Haematologica|May 12, 2018
End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R: a paradigm shift in clinical decision makingChristopher Melani, Ranjana Advani, Mark Roschewski, et al.
British Journal of Haematology|October 31, 2009
Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T-cell lymphomaSusan E Bates, Zhirong Zhan, Kenneth Steadman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2006
A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancerPhilip M Arlen, James L Gulley, Catherine Parker, et al.
Blood|September 25, 2015
ATM deficiency promotes development of murine B-cell lymphomas that resemble diffuse large B-cell lymphoma in humansKaren S Hathcock, Hesed M Padilla-Nash, Jordi Camps, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 11, 2009
Strategies to improve long-term outcome in stage IIIB inflammatory breast cancer: multimodality treatment including dose-intensive induction and high-dose chemotherapyClaude Sportès, Seth M Steinberg, David J Liewehr, et al.
Blood Advances|August 8, 2022
The impact of race, ethnicity, and obesity on CAR T-cell therapy outcomesAiman J Faruqi, John A Ligon, Paul Borgman, et al.
Pageof 49